Pacific Biosciences Of California | PACB - Operating Expenses


Pacific Biosciences Of California reported $97.83M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.43B 2M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Danaher USD 53.62B 1.04B Sep/2026
General Electric Aerospace USD 17.52B 118M Sep/2026
Illumina USD 899M 47M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 646.2M 1.21B Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Standard Biotools USD 30.56M 15.16M Mar/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Waters USD 527M 592M Jun/2026